Key result
CCTA plaque quantification and AI-guided phenotyping refine cardiovascular risk prediction beyond luminal stenosis.
Why the study?
Plaque quantification and phenotyping using CCTA, including artificial intelligence-based quantitative plaque analysis, is a promising approach for guiding individualized cardiovascular preventive management, warranting a review of its role in CAD diagnosis and risk assessment.
Answers are grounded in this paper and cite their sources.
This review highlights that incorporating CCTA-based plaque quantification and phenotyping, including AI-based analysis, refines traditional cardiovascular risk prediction and helps individualize preventive management strategies.
Purpose of review In this review, we outline the role coronary computed tomography angiography (CCTA) plays in the diagnosis of coronary artery disease (CAD) and in facilitating risk assessment. Plaque quantification and phenotyping using CCTA is a promising approach in guiding cardiovascular preventive management. Recent findings There is growing interest in how artificial intelligence-based quantitative plaque analysis using CCTA (AI-CPA) can guide preventive therapy. The review summarizes studies that show prognostic utility of CCTA-derived plaque quantification and phenotyping as well as outlines more recent studies that show the impact of AI-CPA in patient management decisions, allowing a more individualized approach to preventive strategies. Summary CCTA provides a comprehensive assessment extending beyond coronary luminal stenosis to include plaque quantification, plaque phenotyping, functional assessment of stenotic lesions and vascular inflammation, further refining traditional approaches of risk prediction. In summary, the growing evidence highlights the importance of incorporating CCTA-based plaque volume and plaque phenotype analysis in better informing physicians about individual's risk and in guiding preventive management.
No takes yet. Share an insight, caveat, or question.
Mengesha et al. (2026) conducted a review in Coronary artery disease. Coronary computed tomography angiography plaque quantification and phenotyping (including AI-CPA) vs. Traditional risk prediction and luminal stenosis assessment was evaluated. CCTA-based plaque quantification and phenotyping, including AI-CPA, refine cardiovascular risk prediction beyond luminal stenosis and help guide individualized preventive management.
Synapse has enriched 10 related papers. Consider them for comparative context: